Revolutionizing clinical trials: How master protocols and adaptive platform trials are changing drug development

Unlocking the Future of Clinical Trials: The Power of Master Protocols

Master protocols revolutionize clinical research by enabling multiple therapies to be tested under a single, flexible framework. This approach accelerates patient access to promising treatments, optimizes resources, and streamlines regulatory approvals. Our white paper explores the key benefits of master protocols and adaptive platform trials (APTs) for stakeholders across the healthcare ecosystem—including patients, clinicians, pharmaceutical companies, and regulators. Discover how organizations like the Global Coalition for Adaptive Research (GCAR) are driving innovation in trial design to transform the future of medicine.

Download the white paper: